Showing results (161-170 of 980) with videos related to
Sort By:
Pageof 98
Pharmaceutical Research|January 8, 2020
Comparison of the Hepatotoxic Potential of Two Treatments for Autosomal-Dominant Polycystic Kidney DiseaseUsing Quantitative Systems Toxicology ModelingJ L Woodhead, L Pellegrini, L K M Shoda, et al.European Review for Medical and Pharmacological Sciences|May 14, 2015
Prevention of vascular damage with Lisosan G wheat extract: the in vitro basis for a clinical investigationR Sacco, L Pucci, V Sivozhelezov, et al.Current Opinion in Neurology|March 28, 2012
Right-to-left shunts and micro-embolization in migraineHille Koppen, Inge H Palm-Meinders, Michel D FerrariExpert Review of Neurotherapeutics|October 9, 2009
Genetic factors in cluster headacheJorine A van Vliet, Michel D Ferrari, Joost HaanNederlands Tijdschrift Voor Geneeskunde|November 24, 2004
[Still no proof of the efficacy of acupuncture in the prevention of migraine]G G Schoonman, N J Wiendels, M D FerrariNeurology|September 1, 1988
Bromocriptine-induced trigeminal neuralgia attacks in a patient with a pituitary tumorM D Ferrari, J Haan, A P van SetersBiotechnology and Bioengineering|October 5, 1992
Ethanol production from eucalyptus wood hemicellulose hydrolysate by Pichia stipitisM D Ferrari, E Neirotti, C Albornoz, et al.Clinical Pharmacology and Therapeutics|November 7, 2008
Are migraineurs at increased risk of adverse drug responses? A meta-analytic comparison of topiramate-related adverse drug reactions in epilepsy and migraineJ Luykx, M Mason, M D Ferrari, et al.Plos One|September 7, 2013
Migraine strikes as neuronal excitability reaches a tipping pointMarten Scheffer, Albert van den Berg, Michel D FerrariMilitary Medicine|November 2, 2024
Military Medical Simulations-Scoping ReviewSophia J Caffery, Brock D Ferrari, Matthew G HackettPageof 98